New therapeutic target in myeloma discovered

(The Mount Sinai Hospital / Mount Sinai School of Medicine) A new study by researchers at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has shown that targeting both CDK4 and ARK5, proteins responsible for maintaining energy balance within the cell, was extremely effective in causing cell death in myeloma